Is Invion Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Invion Ltd (IVX.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Invion Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Invion Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Invion Ltd?

Muslim investors may consider investing in Invion Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Invion Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Invion Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Invion Ltd updated?

The Shariah compliance status of Invion Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Invion Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Invion Ltd?

You can check the latest Shariah compliance status of Invion Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

IVX.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 30, 2025

Report Source: 2025 2nd Quarter Report

Invion Ltd. Stock Analysis IVX.AX

Australia Health Care Nano Cap Report: Q2, 2025

Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. The company holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.

Key Statistics of Invion Ltd (IVX.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.06AUD0.06

Today's Open

AUD0.06

Volume

219.15K

P/E Ratio (TTM)

52 Week Range

AUD0.06AUD0.20

Market Cap

6.01M

Avg. Volume

47.24K

Dividend Yield

Financial Metrics & Statements of Invion Ltd (IVX.AX)

FAQ's for Invion Ltd (IVX.AX)

According to Musaffa’s Shariah screening methodology, Invion Ltd (IVX.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.